SCINAI IMMUNOTHERAPEUTICS LTD. Shortterm Employee Benefits Expense
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Shortterm Employee Benefits Expense of ILS 1.66 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-28.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ShorttermEmployeeBenefitsExpense · last filed 2022-03-28
ILS
| Period end | Shortterm Employee Benefits Expense 12 month |
|---|---|
| 2021-12-31 | 1.66M ILS 20-F · filed 2022-03-28 |
| 2020-12-31 | 824.00K ILS 20-F · filed 2022-03-28 |
| 2019-12-31 | 1.85M ILS 20-F · filed 2022-03-28 |
| 2018-12-31 | 1.90M ILS 20-F · filed 2021-05-13 |
| 2017-12-31 | 1.97M ILS 20-F · filed 2020-06-12 |
| 2016-12-31 | 1.74M ILS 20-F · filed 2019-04-30 |
| 2015-12-31 | 1.73M ILS 20-F · filed 2018-04-30 |
USD
| Period end | Shortterm Employee Benefits Expense 12 month |
|---|---|
| 2021-12-31 | $532.00K 20-F · filed 2022-03-28 |
| 2020-12-31 | $256.00K 20-F · filed 2021-05-13 |
| 2017-12-31 | $569.00K 20-F · filed 2018-04-30 |